Infectious Disease Clinics of North America
Volume 24, Issue 3 , Pages 603-617, September 2010

Emerging, Novel, and Known Influenza Virus Infections in Humans

  • Julian W. Tang, PhD, MRCP, FRCPath

      Affiliations

    • Division of Microbiology, Department of Laboratory Medicine, National University Hospital, 5 Lower Kent Ridge Road, Singapore 119074, Singapore
    • Molecular Diagnosis Centre, Department of Laboratory Medicine, National University Hospital, 5 Lower Kent Ridge Road, Singapore 119074, Singapore
    • Corresponding Author InformationCorresponding author. Division of Microbiology, Department of Laboratory Medicine, National University Hospital, 5 Lower Kent Ridge Road, Singapore 119074, Singapore.
  • ,
  • Nandini Shetty, MSc, MD, FRCPath

      Affiliations

    • Department of Clinical Microbiology, University College London Hospitals, 1st floor, Windeyer Institute of Medical Sciences, 46 Cleveland Street, London W1T 4JF, UK
  • ,
  • Tommy T.Y. Lam, PhD

      Affiliations

    • School of Biological Sciences, Kadoorie Biological Sciences Building, The University of Hong Kong, Pokfulam Road, Hong Kong Special Administrative Region, China
  • ,
  • K.L. Ellis Hon, MD, FCCM

      Affiliations

    • Department of Paediatrics, The Chinese University of Hong Kong, Shatin, Hong Kong Special Administrative Region, China

Influenza viruses continue to cause yearly epidemics and occasional pandemics in humans. In recent years, the threat of a possible influenza pandemic arising from the avian influenza A(H5N1) virus has prompted the development of comprehensive pandemic preparedness programs in many countries. The recent emergence of the pandemic influenza A(H1N1) 2009 virus from the Americas in early 2009, although surprising in its geographic and zoonotic origins, has tested these preparedness programs and revealed areas in which further work is necessary. Nevertheless, the plethora of epidemiologic, diagnostic, mathematical and phylogenetic modeling, and investigative methodologies developed since the severe acute respiratory syndrome outbreak of 2003 and the subsequent sporadic human cases of avian influenza have been applied effectively and rapidly to the emergence of this novel pandemic virus. This article summarizes some of the findings from such investigations, including recommendations for the management of patients infected with this newly emerged pathogen.

Keywords: Influenza, Pandemic, H1N1, Transmission, Treatment, Epidemiology

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Funding: no specific funding was involved in the writing of this article.

PII: S0891-5520(10)00028-0

doi:10.1016/j.idc.2010.04.001

Infectious Disease Clinics of North America
Volume 24, Issue 3 , Pages 603-617, September 2010